SAN FRANCISCO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision oral appliance therapy (OAT) for the treatment of Obstructive Sleep Apnea (OSA), ...
Beyond Air's LungFit PH receives TGA authorization in Australia for delivering nitric oxide via ventilators, enhancing respiratory care capabilities. The press release includes multiple ...
Additional reimbursement coverage further expands the market for ProSomnus as the Company seeks to make precision oral appliance therapy a first-line treatment for obstructive sleep apnea SAN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback